Pulmonary Hypertension

December 28, 2014November 5, 2015

Economic Burden of Treating Pulmonary Arterial Hypertension Eased Through Effective Use of Therapeutics

A new study entitled “The economic burden of pulmonary arterial hypertension (PAH) in the U.S. on payers and patients” found that medical costs of patients with pulmonary arterial hypertension (PAH) decrease ... Read more

December 26, 2014November 5, 2015

Pulmonary Embolism Patients with High BMI “Benefit Considerably” From Apixaban Therapy

News, Pulmonary Hypertension

Deep vein thrombosis is characterized by the formation of a blood clot inside a deep vein, generally in the legs, blocking blood-circulation. When the blood clot detaches — embolus — ... Read more

December 18, 2014November 5, 2015

Researchers Develop New Diagnostic Tool To Detect Pulmonary Embolisms in Patients Over 50

News, Pulmonary Hypertension

A recent study entitled “Assessment of the Safety and Efficiency of Using an Age-Adjusted D-dimer Threshold to Exclude Suspected Pulmonary Embolism” suggests that adjusting the value of d-dimer test according ... Read more

December 17, 2014November 5, 2015

Researchers Offer Insights Into Use of Right Heart Catheter Measurements, CMR Volumetrics in CTEPH

News, Pulmonary Hypertension

A new study on chronic thromboembolic pulmonary hypertension entitled “Right ventricular adaptation to pulmonary pressure load in patients with chronic thromboembolic pulmonary hypertension before and after successful pulmonary endarterectomy – ... Read more

December 12, 2014November 5, 2015

GSK Submits Ambrisentan for PAH Treatment to European Medicines Agency

News, Pulmonary Hypertension

Research-based pharmaceutical and healthcare company GSK has completed regulatory submission to the European Medicines Agency (EMA) regarding a series of Marketing Authorizations for ambrisentan (Volibris), their therapy for pulmonary arterial hypertension (PAH). ... Read more

December 4, 2014November 5, 2015

Experimental Pulmonary Arterial Hypertension Drug Selexipag Submitted To European Medicines Agency

News, Pulmonary Hypertension

Actelion Ltd, a biopharmaceutical company developing innovative therapeutics for orphan diseases, submitted a Marketing Authorization Application (MAA) for their lead investigational drug selexipag (Uptravi®) to the European Medicines Agency (EMA) as a new therapeutic for ... Read more

December 1, 2014November 5, 2015

PH Diagnosis, Treatment Aided By New Right Ventricle 4D RV-Function Imaging Systems

News, Pulmonary Hypertension

Munich, Germany based TomTec Imaging Systems GmbH’s 4D RV-Function software has been developed to give clinicians a comprehensive evaluation of the right ventricle including volumes and strain analysis. Because pulmonary ... Read more

November 25, 2014November 5, 2015

UC San Diego Health System Receives Launches National Chronic Thromboembolic Pulmonary Hypertension Registry

News, Pulmonary Hypertension

UC San Diego Health System is launching the first national chronic thromboembolic pulmonary hypertension (CTEPH) registry to improve healthcare practices and patient care for those with the disease, thanks to ... Read more

November 24, 2014November 5, 2015

Surgical Cure for CTEPH Available in Vanderbilt Medical Center

News, Pulmonary Hypertension

A number of patients who were suffering from a type of pulmonary hypertension known as CTEPH, or chronic thromboembolic pulmonary hypertension, have gotten their normal life back after undergoing a breakthrough ... Read more

November 21, 2014November 5, 2015

Photo Contest Launched on First Annual CTEPH Awareness Day by Bayer

News, Pulmonary Hypertension

Bayer HealthCare Pharmaceuticals is launching an awareness and patient support campaign to support those suffering from chronic thromboembolic pulmonary hypertension (CTEPH), a type of pulmonary hypertension (PH) that provokes blood clots in the ... Read more